Fractyl Health (GUTS) Invested Capital (2023 - 2026)

Fractyl Health (GUTS) has reported Invested Capital for 4 consecutive years, with $28.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital rose 144.47% year-over-year to $28.8 million; the trailing twelve-month figure through Jun 2026 stood at $28.8 million (up 144.47% YoY), and the FY2025 full-year result was $40.0 million, down 31.65% from the prior year.
• Invested Capital was $28.8 million for Q2 2026 at Fractyl Health, down from $51.5 million in the prior quarter.
• The five-year high for Invested Capital was $112.9 million in Q1 2024, with the low at -$269.9 million in Q4 2023.
• Historically, Invested Capital has averaged $25.2 million across 4 years, with a median of $40.0 million in 2025.
• Annual changes were most pronounced in 2025 — Invested Capital plunged 88.12% — and 2026, when it soared 144.47%.
• Tracing GUTS's Invested Capital over 4 years: stood at -$269.9 million in 2023, then surged by 121.71% to $58.6 million in 2024, then plunged by 31.65% to $40.0 million in 2025, then dropped by 28.13% to $28.8 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $28.8 million in Q2 2026, $51.5 million in Q1 2026, and $40.0 million in Q4 2025.